Arvia E. Morris

555 total citations
15 papers, 437 citations indexed

About

Arvia E. Morris is a scholar working on Molecular Biology, Genetics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Arvia E. Morris has authored 15 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Genetics and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Arvia E. Morris's work include Viral Infectious Diseases and Gene Expression in Insects (8 papers), Protein purification and stability (5 papers) and Virus-based gene therapy research (4 papers). Arvia E. Morris is often cited by papers focused on Viral Infectious Diseases and Gene Expression in Insects (8 papers), Protein purification and stability (5 papers) and Virus-based gene therapy research (4 papers). Arvia E. Morris collaborates with scholars based in United States and Canada. Arvia E. Morris's co-authors include Lawrence A. Chasin, Richard J. Armitage, Richard L. Remmele, Carter Bancroft, Teri L. Aldrich, Ruth McChesney, Brian M. Macduff, William C. Fanslow, Brian Kloss and Brian D. Follstad and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Arvia E. Morris

15 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arvia E. Morris United States 10 295 112 112 83 51 15 437
Erik Vernet Denmark 9 278 0.9× 65 0.6× 44 0.4× 30 0.4× 18 0.4× 17 405
Stephanie A. Camacho Germany 7 77 0.3× 52 0.5× 288 2.6× 64 0.8× 19 0.4× 8 460
Bernhard Föllmer United States 6 262 0.9× 31 0.3× 146 1.3× 86 1.0× 50 1.0× 8 447
Sreekumar Kodangattil United States 7 231 0.8× 196 1.8× 125 1.1× 13 0.2× 28 0.5× 9 368
Maria Frangou‐Lazaridis Greece 14 280 0.9× 30 0.3× 71 0.6× 28 0.3× 24 0.5× 19 381
H von Boehmer Switzerland 11 172 0.6× 177 1.6× 644 5.8× 48 0.6× 17 0.3× 15 811
Christian Y. Arod United States 7 200 0.7× 81 0.7× 82 0.7× 25 0.3× 4 0.1× 9 305
Brooke Lumicisi United Kingdom 5 184 0.6× 126 1.1× 124 1.1× 25 0.3× 5 0.1× 5 346
Myriam Gwerder Switzerland 8 364 1.2× 126 1.1× 94 0.8× 50 0.6× 3 0.1× 9 519
Martin Bader Germany 8 267 0.9× 178 1.6× 117 1.0× 95 1.1× 3 0.1× 12 416

Countries citing papers authored by Arvia E. Morris

Since Specialization
Citations

This map shows the geographic impact of Arvia E. Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arvia E. Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arvia E. Morris more than expected).

Fields of papers citing papers by Arvia E. Morris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arvia E. Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arvia E. Morris. The network helps show where Arvia E. Morris may publish in the future.

Co-authorship network of co-authors of Arvia E. Morris

This figure shows the co-authorship network connecting the top 25 collaborators of Arvia E. Morris. A scholar is included among the top collaborators of Arvia E. Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arvia E. Morris. Arvia E. Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Zupke, Craig, Lowell J. Brady, Peter G. Slade, et al.. (2015). Real‐time product attribute control to manufacture antibodies with defined N‐linked glycan levels. Biotechnology Progress. 31(5). 1433–1441. 33 indexed citations
2.
Morris, Arvia E., et al.. (2015). Factors that determine stability of highly concentrated chemically defined production media. Biotechnology Progress. 31(2). 493–502. 21 indexed citations
3.
Du, Zhimei, John D. McCarter, Dina Fomina‐Yadlin, et al.. (2014). Use of a small molecule cell cycle inhibitor to control cell growth and improve specific productivity and product quality of recombinant proteins in CHO cell cultures. Biotechnology and Bioengineering. 112(1). 141–155. 92 indexed citations
4.
Fomina‐Yadlin, Dina, John J. Gosink, Brian D. Follstad, et al.. (2013). Cellular responses to individual amino‐acid depletion in antibody‐expressing and parental CHO cell lines. Biotechnology and Bioengineering. 111(5). 965–979. 31 indexed citations
5.
Jacobsen, Frederick W., Arvia E. Morris, Teri L. Aldrich, et al.. (2010). Molecular and Functional Characterization of Cynomolgus Monkey IgG Subclasses. The Journal of Immunology. 186(1). 341–349. 34 indexed citations
6.
Aldrich, Teri L., Aurora Viaje, & Arvia E. Morris. (2003). EASE Vectors for Rapid Stable Expression of Recombinant Antibodies. Biotechnology Progress. 19(5). 1433–1438. 20 indexed citations
7.
Wong-Madden, Sharon, et al.. (2002). Over-expression of protein kinase Bα enhances recombinant protein expression in transient systems. Cytotechnology. 38(1-3). 11–14. 4 indexed citations
8.
Matsuura, James E., Arvia E. Morris, Randal R. Ketchem, et al.. (2001). Biophysical Characterization of a Soluble CD40 Ligand (CD154) Coiled-Coil Trimer: Evidence of a Reversible Acid-Denatured Molten Globule. Archives of Biochemistry and Biophysics. 392(2). 208–218. 12 indexed citations
9.
Wong-Madden, Sharon, et al.. (2001). Over-Expression of Protein Kinase Bα Enhances Recombinant Protein Expression in Transient Systems. PubMed. 38(1-3). 31–36. 6 indexed citations
10.
Morris, Arvia E., et al.. (1999). Incorporation of an Isoleucine Zipper Motif Enhances the Biological Activity of Soluble CD40L (CD154). Journal of Biological Chemistry. 274(1). 418–423. 84 indexed citations
11.
Aldrich, Teri L., James N. Thomas, & Arvia E. Morris. (1998). Improved bicistronic mammalian expression vectors using expression augmenting sequence element (EASE). Cytotechnology. 28(1-3). 9–17. 5 indexed citations
12.
Morris, Arvia E., Brian Kloss, Ruth McChesney, Carter Bancroft, & Lawrence A. Chasin. (1992). An alternatively spliced Pit-1 isoform altered in its ability to trans-activate. Nucleic Acids Research. 20(6). 1355–1361. 72 indexed citations
13.
Ciudad, Carlos J., Arvia E. Morris, Chin-Ming Jeng, & Lawrence A. Chasin. (1992). Point mutational analysis of the hamster dihydrofolate reductase minimum promoter.. Journal of Biological Chemistry. 267(6). 3650–3656. 16 indexed citations
14.
Morris, Arvia E., et al.. (1990). Use of a selectable reporter for the isolation of mammalian regulatory genes. Gene. 94(2). 289–294. 4 indexed citations
15.
Morris, Arvia E., et al.. (1989). Isolation of novel cDNA transformation markers from SV40-transformed human keratinocytes. Experimental Cell Research. 182(2). 461–472. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026